Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
18.56
-1.70 (-8.37%)
At close: Oct 13, 2026, 4:00 PM EDT
18.66
+0.10 (0.54%)
After-hours: Oct 13, 2026, 5:33 PM EDT
Damora Therapeutics Market Cap
Damora Therapeutics has a market cap or net worth of $1.15 billion as of October 13, 2026. It is the 9,008th most valuable company in the world and the 2,098th biggest in the United States. Its market cap has increased by 6,732.94% in one year.
Market Cap
1.15B
Enterprise Value
605.30M
1-Year Change
6,732.94%
Global Rank
Country Rank
#2,098 United States
Category
ChartMarket Cap Chart
Since October 29, 2020, Damora Therapeutics's market cap has increased from $368.78M to $1.15B, an increase of 210.70%. That is a compound annual growth rate of 20.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 1.15B | 3,017.48% |
| Dec 31, 2025 | 36.75M | 500.17% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Taysha Gene Therapies | 1.35B |
| Tyra Biosciences | 1.35B |
| Kardigan | 1.34B |
| Inhibrx Biosciences | 1.33B |
| Alpha Tau Medical | 1.32B |
| Replimune Group | 1.23B |
| Savara | 1.23B |
| ORIC Pharmaceuticals | 1.22B |